About
TeleRescue is developing an autonomous defibrillation system that can sense the occurrence of sudden cardiac arrest and apply defibrillation to the patient without the presence of a caregiver. The system is composed of an ECG-sensing module and a defibrillator module. The ECG-sensing module is permanently attached to the patient and continuously transmits data to the defibrillator module, which is lightweight, comfortable, and suitable for an indefinite period of use. The defibrillator module can be attached to the patient or rest on the charging module in standby mode for immediate attachment and activation. This module receives the ECG data in wireless mode, evaluates it, and then either applies defibrillation directly or sends the data to a medical call center that can send back a defibrillation command. The module has additional voice-communication features and automatically transmits the patients location for use by a follow-up team.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is TeleRescue's primary focus?
- TeleRescue is developing an autonomous defibrillation system designed to detect sudden cardiac arrest and deliver defibrillation without a caregiver present.
- When was TeleRescue founded?
- TeleRescue was founded in January 2011.
- What is the operational status of TeleRescue?
- TeleRescue is currently inactive and ceased operations in June 2019.
- Where is TeleRescue headquartered?
- TeleRescue is headquartered in Tel Aviv-Yafo, Israel.
- How many employees does TeleRescue have?
- TeleRescue has 3 employees.
- What is TeleRescue's current funding stage?
- TeleRescue is in the Pre-Funding stage.
- Who is a key founder of TeleRescue?
- Dr. Israel Shamir Lebovitz is a founder of TeleRescue.
- Does TeleRescue hold any patents?
- Yes, TeleRescue holds 1 patent.